Seth Loring Harrison Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Seth Loring Harrison.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Seth Loring Harrison. Seth Loring Harrison is a Director in HeartWare International, Inc. ($HTWR) and a in Tokai Pharmaceuticals Inc ($TKAI) and a Director in Stoke Therapeutics, Inc. ($STOK) and a Director in Akero Therapeutics, Inc. ($AKRO).
Address: C/O SUITE 4, LEVEL 46, 2 PARK STREET SYDNEY, NSW 2000Australia
Companies in which Seth Loring Harrison is an Insider
Akero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Seth Loring Harrison: Director
Holdings: 5,830,203 shares
Latest Transaction: Jul 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eledon Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Seth Loring Harrison:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2016
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HeartWare International, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Seth Loring Harrison: Director
Holdings: 0 shares
Latest Transaction: Aug 24 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Stoke Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Seth Loring Harrison: Director
Holdings: 17,161,713 shares
Latest Transaction: Nov 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Seth Loring Harrison
Sentiment: All, AKRO, ELDN, HTWR, STOK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2020 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 39.00 | 375,000 | 14,625,000 | 17,161,713 | 16.8 M to 17.2 M (+2.23 %) |
| Jul 14 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 36.00 | 415,000 | 14,940,000 | 5,830,203 | 5.4 M to 5.8 M (+7.66 %) |
| Jul 14 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Buy | P | 36.00 | 415,000 | 14,940,000 | 5,830,203 | 5.4 M to 5.8 M (+7.66 %) |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Jun 02 2020 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
| Nov 12 2019 | AKRO | Akero Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 19.97 | 26,000 | 519,220 | 26,000 | |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | Harrison Seth Loring | Director | Option Exercise | A | 28.80 | 29,555 | 851,184 | 29,555 |